Come up with a name for your new list and we'll add to it:
Provectus Pharmaceuticals raised a round of funding on November 08, 2002. Investors include
Gryffindor Capital Partners.
Provectus Pharmaceuticals (OTCQB: PVCT) is a clinical-stage biopharmaceutical company developing new therapies for the treatment of solid tumor cancers and dermatologic diseases. Provectus' investigat…